PubRank

A Comparison of Prasugrel and Clopidogrel in Acute Coronary Syndrome Subjects (TRILOGY ACS)

Clinical Trial ID NCT00699998

PubWeight™ 28.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00699998

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Prasugrel versus clopidogrel for acute coronary syndromes without revascularization. N Engl J Med 2012 4.49
2 Prasugrel versus clopidogrel for patients with unstable angina or non-ST-segment elevation myocardial infarction with or without angiography: a secondary, prespecified analysis of the TRILOGY ACS trial. Lancet 2013 2.22
3 Platelet function during extended prasugrel and clopidogrel therapy for patients with ACS treated without revascularization: the TRILOGY ACS platelet function substudy. JAMA 2012 2.22
4 Applying novel methods to assess clinical outcomes: insights from the TRILOGY ACS trial. Eur Heart J 2014 2.06
5 Ticagrelor versus clopidogrel in patients with acute coronary syndromes intended for non-invasive management: substudy from prospective randomised PLATelet inhibition and patient Outcomes (PLATO) trial. BMJ 2011 1.74
6 Antiplatelet therapies for the treatment of cardiovascular disease. Nat Rev Drug Discov 2010 1.66
7 Impact of Human Development Index on the profile and outcomes of patients with acute coronary syndrome. Heart 2014 1.48
8 Impact of CYP2C19 Metabolizer Status on Patients With ACS Treated With Prasugrel Versus Clopidogrel. J Am Coll Cardiol 2016 1.40
9 Spontaneous MI After Non-ST-Segment Elevation Acute Coronary Syndrome Managed Without Revascularization: The TRILOGY ACS Trial. J Am Coll Cardiol 2016 1.37
10 Study design and rationale of a comparison of prasugrel and clopidogrel in medically managed patients with unstable angina/non-ST-segment elevation myocardial infarction: the TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes (TRILOGY ACS) trial. Am Heart J 2010 1.07
11 The evolution of antiplatelet therapy in cardiovascular disease. Nat Rev Cardiol 2011 0.93
12 New antithrombotic agents--insights from clinical trials. Nat Rev Cardiol 2010 0.84
13 Importance of potent P2Y(12) receptor blockade in acute myocardial infarction: focus on prasugrel. Expert Opin Pharmacother 2012 0.78
14 Meta-analysis of intracranial hemorrhage in acute coronary syndromes: incidence, predictors, and clinical outcomes. J Am Heart Assoc 2015 0.78
15 Impact of smoking status on platelet function and clinical outcomes with prasugrel vs. clopidogrel in patients with acute coronary syndromes managed without revascularization: Insights from the TRILOGY ACS trial. Am Heart J 2014 0.77
16 Long-term outcomes for women versus men with unstable angina/non-ST-segment elevation myocardial infarction managed medically without revascularization: insights from the TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes trial. Am Heart J 2015 0.76
17 Antiplatelet agents for chronic kidney disease. Cochrane Database Syst Rev 2022 0.75
18 Ascertainment, classification, and impact of neoplasm detection during prolonged treatment with dual antiplatelet therapy with prasugrel vs. clopidogrel following acute coronary syndrome. Eur Heart J 2015 0.75
19 Time-Varying Effects of Prasugrel Versus Clopidogrel on the Long-Term Risks of Stroke After Acute Coronary Syndromes: Results From the TRILOGY ACS Trial. Stroke 2016 0.75
20 Antiplatelet therapy in acute coronary syndromes: current agents and impact on patient outcomes. Patient Relat Outcome Meas 2010 0.75
21 Improving outcomes in patients undergoing percutaneous coronary intervention: role of prasugrel. Vasc Health Risk Manag 2009 0.75
22 Platelet function analysis: at the edge of meaning. Thromb Haemost 2009 0.75
23 Relationship of Platelet Reactivity With Bleeding Outcomes During Long-Term Treatment With Dual Antiplatelet Therapy for Medically Managed Patients With Non-ST-Segment Elevation Acute Coronary Syndromes. J Am Heart Assoc 2016 0.75
24 Effect of prior clopidogrel use on outcomes in medically managed acute coronary syndrome patients. Heart 2016 0.75
Next 100